Table 1.

Patient demographic and clinical data, including blood sampling time points

Patient ID	Age (years)	Weight (kg)	Administered activity (MBq)	Gleason score	Number of bone metastases	Pretreatments	Nominal blood sampling time points: time after administration
P1	63	95	5.5	9	Disseminated, > 50	Prostatectomy	Before administration, 1.5 h, 3 h, 4 h, 24 h, 48 h
P2	72	103	5.6	8	Approx. 5	None	Before administration, 1.5 h, 3 h, 4 h
P3	76	78	4.6	9	Disseminated, > 50	Prostatectomy, ADT, local RTx,	Before administration, 1.5 h, 3 h, 4 h
P4	78	63	3.3	8	Disseminated, > 50	Prostatectomy, ADT, CTx, RTx	Before administration, 1.5 h, 3 h, 4 h
P5	57	85	4.6	9	Disseminated, > 50	Prostatectomy, ADT, RTx, CTx	Before administration, 1 h, 2 h, 3 h
P6	72	89	4.9	9	Disseminated, > 50	Prostatectomy, ADT, CTx, RTx	Before administration, 1.5 h, 3 h, 4 h
P7	72	90	4.9	9	Disseminated, > 20	Prostatectomy, ADT, RTx	Before administration, 1.5 h, 3 h, 4 h, 24 h, 96 h, 28 d
P8	76	73	4.0	9	Approx. 10	Prostatectomy, ADT, RTx	Before administration, 1.5 h, 3 h, 4 h, 24 h, 48 h, 28 d
P9	70	77	4.2	7	Disseminated, > 200	Prostatectomy, ADT, RTx	Before administration, 1.5 h, 3 h, 4 h, 24 h, 30 d

ADT, androgen deprivation therapy; CTx, chemotherapy; RTx, external-beam radiation therapy